Anionic wormlike micelles, particularly those formed by long-chain carboxylate surfactants, are relatively less documented though their cationic or zwitterionic counterparts are frequently reported. In this study, the wormlike micelles of sodium erucate (NaOEr), a C22-tailed anionic surfactant with a monounsaturated tail, in the presence of a tetraalkylammonium hydrotrope were investigated for the first time. The different effects of two hydrotropes, benzyl trimethyl ammonium bromide (BTAB) and tetramethyl ammonium bromide (TMAB), on the phase behavior and rheological behaviors were compared, and the influences of surfactant concentration and temperature on the rheological properties of NaOEr solutions were also examined. Both organic salts can lower the Krafft temperature of NaOEr solutions and thus improve its water solubility, but BTAB can make T(K) drop more sharply. At a fixed NaOEr concentration, less BTAB is demanded to induce the formation of viscoelastic solution and to obtain the maximum viscosity of NaOEr solution; at a constant salt concentration, with increasing NaOEr content, the NaOEr-BTAB system shows a larger zero-shear viscosity (η(0)), relaxation time, and plateau modulus but lower overlapping concentration than those of the NaOEr-TMAB system. The occurrence of maximum η(0) with increasing salt content for the NaOEr-BTAB system results from the formation of vesicles and L(3) phases, which were verified by cryo-TEM observations. η(0) shows an exponential decrease with increasing temperature; nevertheless it still remains above 10(3) mPa·s even at 90 °C.
Purinergic 2X7 receptor (P2X7R) and nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) are expressed in macrophages in atherosclerotic lesions. However, the mechanisms through which P2X7R participates in the inflammatory response in atherosclerosis remain largely unknown. The aim of the present study was to investigate the role of P2X7R in atherosclerosis and the mechanisms of action of the NLRP3 inflammasome following stimulation with oxidized low-density lipoprotein (oxLDL). We observed the expression and distribution of P2X7R in the atherosclerotic plaque in the coronary arteries from an autopsy specimen and in that of the aortic sinuses of apoE−/− mice by immunohistochemistry and immunofluorescence staining. The specificity of short interfering RNA (siRNA) was used to suppress P2X7R and NLRP3 mRNA expression. RT-qPCR and western blot analysis were used to analyze mRNA and protein expression, respectively. Co-immunoprecipitation was used to examine the interaction between protein kinase R (PKR) phosphorylation and NLRP3. P2X7R and NLRP3 were expressed at high levels in the atherosclerotic plaque in the coronary arteries. Stimulation with oxLDL upregulated P2X7R, NLRP3 and interleukin (IL)-1β expression. P2X7R knockdown by siRNA suppressed NLRP3 inflammasome activation by inhibiting the PKR phosphorylation mediated by oxLDL. In the atherosclerotic lesions in the aortic sinuses of apoE−/− mice, P2X7R expression was found at high levels. Moreover, P2X7R siRNA attenuated the development of atherosclerosis in the apoE−/− mice. In conclusion, our results demonstrate that P2X7R plays a significant role in the development of atherosclerosis and regulates NLRP3 inflammasome activation by promoting PKR phosphorylation.
Purpose:
The purpose of our study was to prospectively evaluate the diagnostic performance of the vascular index (VI, defined as the ratio of Doppler signal pixels to pixels in the total lesion) measured via Smart 3-D superb microvascular imaging (SMI) for breast lesions.
Patients and methods:
Two hundred and thirty-two consecutive patients with 236 breast lesions referred for biopsy at Peking Union Medical College Hospital were enrolled in the study from December 2016 to November 2017. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of VI were calculated with histopathologic results as the reference standard.
Results:
Of the 236 breast lesions, 121 were malignant and 115 were benign. The mean VI was significantly higher in malignant lesions (9.7±8.2) than that in benign ones (3.4±3.3) (
P
<0.0001). Sensitivity, specificity, PPV, NPV and accuracy of VI (4.0 as the threshold) were respectively: 76.0%, 66.1%, 70.2%, 72.4% and 71.2% (
P
<0.05).
Conclusion:
Smart three-dimensional (3-D) SMI is a noninvasive tool using two-dimensional (2-D) scanning to generate 3-D vascular architecture with a high-resolution image of micro-vessels. This can be used as a qualitative guide to identify the optimal 2-D SMI plane with the most abundant vasculature to guide VI quantitative measurements of breast lesions. Smart 3-D SMI may potentially serve as a noninvasive tool to accurately characterize benign versus malignant breast lesions.
The contribution of fiber alignment of scaffold on cellular mechanisms was evaluated by a comparative study of two different cells sourced from cornea. Electrospun scaffolds with similar composition and comparable fiber size were fabricated into randomly oriented and aligned scaffolds, which bear paralleled degradation of gelatin. Tensile test of wet scaffolds indicated that fiber alignment could influence its mechanical properties. Due to the unidirectional fiber orientation, aligned scaffold exhibited higher tensile modulus, higher break strength, and lower elongation at break than randomly oriented scaffold. The effect of fiber alignment on cells behavior was evaluated by cell morphology, specific protein expression, adhesion, and proliferation. Different corneal cells responded uniquely to fiber alignment of scaffold, keratocytes interacting more favorably on alignment scaffold and corneal epithelial cells more favorably on randomly oriented scaffold. These results confirmed that fiber alignment of scaffold would be benefit for cell proliferation if its contact guidance coincided with the cell shape and cytoskeletal tension. This finding is important to envisage an advanced composite scaffold that incorporates randomly oriented and aligned fibers for the growth and control of different cell types required for the successful development of corneal grafts by tissue engineering.
We decided to assess the prognostic value of NLRP3 inflammasome level in acute coronary syndrome (ACS) patients and whether it was related to coronary atherosclerotic severity. Study population included one-hundred and twenty-three (123) subjects. Peripheral blood monocyte NLRP3 protein level was correlated with clinical presentation, angiographic characteristics and its scoring systems as well as GRACE and TIMI risk scores. Follow-up for major adverse cardiac events (MACE) was carried out at 180 days. Peripheral blood monocyte NLRP3 was found to be elevated in ACS patients (P < 0.05) and showed positive correlation with GRACE score (r = 0.619), TIMI score (r = 0.580), SYNTAX score (r = 0.550), Clinical SYNTAX score (r = 0.564) and Gensini score (r = 0.516). NLRP3 was also increased with increasing number of vessels, the number of lesions present and the presence bifurcation lesions (P < 0.05). Multivariate Cox regression analysis showed NLRP3 to be an independent predictor of MACE (P = 0.043). Kaplan-Meier analysis and receiver operating characteristic curves for NLRP3 showed good predictive value for MACE. There is a positive correlation of NLRP3 level with severity of coronary atherosclerosis. NLRP3 level is a promising prognostic utility and is efficient in event prediction for MACE.
Background and Purpose: Cardiac myxoma is a major primary heart tumor which often causes unexpected symptoms or sudden death. This present study was designed to investigate its clinical pathological features and biological behavior.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.